First Time Loading...

DENTSPLY SIRONA Inc
NASDAQ:XRAY

Watchlist Manager
DENTSPLY SIRONA Inc Logo
DENTSPLY SIRONA Inc
NASDAQ:XRAY
Watchlist
Price: 28.38 USD -5.96% Market Closed
Updated: May 3, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Balance Sheet

7.4B
+2%
Assets
Growth Rates:
1 Year
-4%
3 Years
-21%
5 Years
-15%
7 Years
-36%
10 Years
+45%
4.1B
+7%
Liabilities
Growth Rates:
1 Year
+6%
3 Years
-8%
5 Years
+14%
7 Years
+18%
10 Years
+60%
3.3B
-2%
Equity
Growth Rates:
1 Year
-14%
3 Years
-33%
5 Years
-36%
7 Years
-59%
10 Years
+30%

Balance Sheet Decomposition
DENTSPLY SIRONA Inc

7.4B
Assets
4.1B
Liabilities
7.4B
Assets
4.1B
Liabilities
Current Assets 2B
Cash & Short-Term Investments 334m
Receivables 756m
Other Current Assets 883m
Non-Current Assets 5.4B
PP&E 978m
Intangibles 4.1B
Other Non-Current Assets 276m
Current Liabilities 1.4B
Accounts Payable 305m
Accrued Liabilities 658m
Other Current Liabilities 462m
Non-Current Liabilities 2.7B
Long-Term Debt 1.8B
Other Non-Current Liabilities 856m

Balance Sheet
DENTSPLY SIRONA Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
152
285
384
321
310
405
438
339
365
334
Cash Equivalents
152
285
384
321
310
405
438
339
365
334
Total Receivables
427
400
636
746
702
782
667
750
685
756
Accounts Receivables
427
400
636
746
702
782
667
750
632
695
Other Receivables
0
0
0
0
0
0
0
0
53
61
Inventory
387
340
517
623
599
562
476
515
627
624
Other Current Assets
241
172
206
313
278
252
217
248
216
259
Total Current Assets
1 207
1 197
1 744
2 003
1 888
2 000
1 798
1 852
1 893
1 973
PP&E Net
589
559
800
876
871
962
967
971
961
978
PP&E Gross
0
559
0
876
871
962
967
0
961
978
Accumulated Depreciation
0
784
0
1 197
1 206
1 233
1 392
0
1 312
1 365
Intangible Assets
671
601
2 958
2 801
2 420
2 176
2 504
2 319
1 903
1 705
Goodwill
2 089
1 988
5 952
4 539
3 431
3 397
3 986
3 976
2 688
2 438
Long-Term Investments
0
0
0
0
0
0
0
0
0
0
Other Long-Term Assets
90
59
103
156
77
69
95
121
198
276
Other Assets
2 089
1 988
5 952
4 539
3 431
3 397
3 986
3 976
2 688
2 438
Total Assets
4 646
N/A
4 403
-5%
11 556
+162%
10 375
-10%
8 687
-16%
8 603
-1%
9 350
+9%
9 239
-1%
7 643
-17%
7 370
-4%
Liabilities
Accounts Payable
133
134
223
284
284
308
302
262
279
305
Accrued Liabilities
371
297
460
560
547
594
627
760
624
640
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
112
12
21
30
92
2
299
182
118
322
Other Current Liabilities
37
33
64
81
90
91
144
57
149
158
Total Current Liabilities
653
476
768
955
1 013
996
1 372
1 261
1 170
1 425
Long-Term Debt
1 150
1 141
1 511
1 612
1 565
1 433
1 978
1 913
1 826
1 796
Deferred Income Tax
166
160
752
718
553
480
381
391
287
228
Minority Interest
1
1
12
12
12
2
3
1
1
1
Other Liabilities
356
286
400
463
423
600
684
677
548
627
Total Liabilities
2 325
N/A
2 065
-11%
3 442
+67%
3 758
+9%
3 566
-5%
3 510
-2%
4 418
+26%
4 243
-4%
3 832
-10%
4 077
+6%
Equity
Common Stock
2
2
3
3
3
3
3
3
3
3
Retained Earnings
3 381
3 591
3 948
2 316
1 226
1 404
1 198
1 514
456
205
Additional Paid In Capital
222
238
6 517
6 544
6 522
6 587
6 604
6 606
6 629
6 643
Unrealized Security Profit/Loss
8
0
0
44
0
0
0
0
0
0
Treasury Stock
842
898
1 647
1 955
2 151
2 301
2 409
2 535
2 649
2 922
Other Equity
450
594
706
335
479
600
464
592
628
636
Total Equity
2 321
N/A
2 338
+1%
8 114
+247%
6 616
-18%
5 121
-23%
5 093
-1%
4 932
-3%
4 996
+1%
3 811
-24%
3 293
-14%
Total Liabilities & Equity
4 646
N/A
4 403
-5%
11 556
+162%
10 375
-10%
8 687
-16%
8 603
-1%
9 350
+9%
9 239
-1%
7 643
-17%
7 370
-4%
Shares Outstanding
Common Shares Outstanding
141
140
230
227
223
221
219
217
215
207

See Also

Summary
XRAY intrinsic value, competitors valuation, and company profile.
DCF Valuation
XRAY stock valuation using Discount Cash Flow valuation method.
Relative Valuation
XRAY stock valuation using valuation multiples.
Wall Street Estimates
XRAY price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
XRAY stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.